Non-Animal Alternative Testing Market Size Worth USD 29.4 Billion By 2030 | CAGR Of 13.5%


(MENAFN- EIN Presswire)

Non-Animal Alternative Testing market Size 2023

increased risk of chronic diseases among millennials, especially older populations, contributing to the non-animal alternative testing market growth

PUNE , MAHARASHTRA, INDIA, February 24, 2023 /einpresswire.com / -- Non-animal alternative testing refers to the use of methods and techniques that do not involve the use of animals for testing the safety or efficacy of drugs, chemicals, cosmetics, or other products. It aims to replace, reduce, or refine the use of animals in laboratory testing and research, which is also known as the 3Rs principles. Non-animal alternative testing is increasingly being used by regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Union's European Chemicals Agency (ECHA), to assess the safety and efficacy of products. The use of non-animal alternative testing methods has many benefits, including reducing animal suffering, improving the accuracy and reliability of testing results, and accelerating the development of new products.

Allied Market Research has published a study report with the title non-animal alternative testing market size was Valued at USD 9.8 billion in 2021 and is Projected to Garner USD 29.4 billion by 2030, registering a CAGR of 13.5% from 2022 to 2030.

The market share for non-animal alternative testing is expected to grow during the forecast period because to the increased risk of chronic diseases among millennials, especially older populations, contributing to the non-animal alternative testing market growth in the upcoming years.

Get Sample PDF Report with Graphs and Figures Here:

Top Non-Animal Alternative Testing Companies:

.VITROCELL Systems GmbH
.Evotec SE
.Biovit
.MB Research Laboratories
.Emulate, Inc.
.TARA Biosystems, Inc.
.Bio-Rad Laboratories, Inc.
.Abbott
.Hurel Corporation
.TissUse GmbH

Non-Animal Alternative Testing market segmentation can be done based on several factors, including:

By Technology

.Cell Culture
.High Throughput
.Molecular Imaging
.OMIC Technology

By Method

.Cellular Assay
.Biochemical Assay
.In-silico
.Ex-vivo

By End User

.Pharmaceutical Industry
.Cosmetics & Household Products
.Diagnostics
.Chemicals Industry
.Food Industry

Purchase the Report:

Key Findings of the Study

.Based on technology, the cell culture technology sub-segment emerged as the global leader in 2020 and the omic technology sub-segment is anticipated to be the fastest growing sub-segment during the forecast period
.Based on method, the cellular assay sub-segment emerged as the global leader in 2020 and the ex-vivo sub-segment is anticipated to be the fastest growing sub-segment during the forecast period
.Based on end-user, the pharmaceutical industry sub-segment emerged as the global leader in 2020 and the chemical industry sub-segment is predicted to show the fastest growth in the upcoming years
.Based on region, the North America market registered the highest market share in 2020 and Asia-Pacific market is predicted to show the fastest growth in the upcoming years

Our Market Research Solution Provides You Answer to Below Mentioned Question:

.Which are the driving factors responsible for the growth of market?
.Which are the roadblock factors of this market?
.What are the new opportunities, by which market will grow in coming years?
.What are the trends of this market?
.Which are main factors responsible for new product launch?
.How big is the global & regional market in terms of revenue, sales and production?
.How far will the market grow in forecast period in terms of revenue, sales and production?
.Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
.How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
.Which region has more opportunities?

By Region Outlook

. North America
(U.S., Canada, Mexico)
. Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
. Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
. LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Top Trending Report:

AT-Home Testing Market:

Resuscitation Devices Market:

Health and Wellness Market:

3D Cell Culture Market:

Molecular diagnostics market:

Digital Pathology Market:

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of“Market Research Reports” and“Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+ +1 503-894-6022
email us here
Visit us on social media:
facebook
twitter
linkedin

MENAFN23022023003118003196ID1105631717


EIN Presswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.